Assessment of Circulating microRNAs in Plasma of Lung Cancer Patients
Lung cancer is the most common cause of cancer deaths worldwide and numerous ongoing research efforts are directed to identify new strategies for its early detection. The development of non-invasive blood-based biomarkers for cancer detection in its preclinical phases is crucial to improve the outco...
Main Authors: | Orazio Fortunato, Mattia Boeri, Carla Verri, Davide Conte, Mavis Mensah, Paola Suatoni, Ugo Pastorino, Gabriella Sozzi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2014-03-01
|
Series: | Molecules |
Subjects: | |
Online Access: | http://www.mdpi.com/1420-3049/19/3/3038 |
Similar Items
-
Data Integration Reveals the Potential Biomarkers of Circulating MicroRNAs in Osteoarthritis
by: Thuan Duc Lao, et al.
Published: (2021-02-01) -
Circulating microRNAs in Medicine
by: Tetiana Pozniak, et al.
Published: (2022-04-01) -
MicroRNAs as Potential Biomarkers in Pituitary Adenomas
by: Simone Donati, et al.
Published: (2021-09-01) -
<i>PlasmiR</i>: A Manual Collection of Circulating microRNAs of Prognostic and Diagnostic Value
by: Spyros Tastsoglou, et al.
Published: (2021-07-01) -
Clinical Translatability of “Identified” Circulating miRNAs for Diagnosing Breast Cancer: Overview and Update
by: Anna Maria Grimaldi, et al.
Published: (2019-06-01)